Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Mirati Therapeutics Inc.

    NASDAQ: MRTX · Real-Time Price · USD
    58.70
    -0.10 (-0.17%)
    At close: Jan 22, 2024, 10:00 PM

    Mirati Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -740.87M -581.78M
    Depreciation & Amortization
    		 2.93M 1.78M
    Stock-Based Compensation
    		 186.19M 113.5M
    Other Working Capital
    		 -1.35M -5.47M
    Other Non-Cash Items
    		 -8.72M 12.11M
    Deferred Income Tax
    		 n/a n/a
    Change in Working Capital
    		 -10.1M 65.59M
    Operating Cash Flow
    		 -570.57M -388.8M
    Capital Expenditures
    		 -4.85M -9.79M
    Cash Acquisitions
    		 -230.65M 579.11M
    Purchase of Investments
    		 -956.7M -1.42B
    Sales Maturities Of Investments
    		 1.19B 843.62M
    Other Investing Acitivies
    		 230.65M -579.11M
    Investing Cash Flow
    		 225.8M -588.9M
    Debt Repayment
    		 n/a n/a
    Common Stock Repurchased
    		 n/a n/a
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 166.94M 505.22M
    Financial Cash Flow
    		 166.94M 505.22M
    Net Cash Flow
    		 -177.82M -472.48M
    Free Cash Flow
    		 -575.42M -398.6M

    Add to Watchlist